SK280161B6 - Substituované deriváty kyseliny pipekolínovej, spô - Google Patents
Substituované deriváty kyseliny pipekolínovej, spô Download PDFInfo
- Publication number
- SK280161B6 SK280161B6 SK1090-94A SK109094A SK280161B6 SK 280161 B6 SK280161 B6 SK 280161B6 SK 109094 A SK109094 A SK 109094A SK 280161 B6 SK280161 B6 SK 280161B6
- Authority
- SK
- Slovakia
- Prior art keywords
- butyl
- tert
- hydroxy
- amino
- piperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85071692A | 1992-03-13 | 1992-03-13 | |
| PCT/CA1993/000096 WO1993018003A1 (fr) | 1992-03-13 | 1993-03-12 | Derivets substitues de l'acide pinecolinique comme inhibiteurs de la protease du virus de l'immunodeficience humaine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK109094A3 SK109094A3 (en) | 1995-05-10 |
| SK280161B6 true SK280161B6 (sk) | 1999-09-10 |
Family
ID=25308925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1090-94A SK280161B6 (sk) | 1992-03-13 | 1993-03-12 | Substituované deriváty kyseliny pipekolínovej, spô |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5807870A (fr) |
| EP (1) | EP0560268B1 (fr) |
| JP (1) | JP3258422B2 (fr) |
| KR (1) | KR950700253A (fr) |
| AP (1) | AP393A (fr) |
| AT (1) | ATE116640T1 (fr) |
| AU (1) | AU670582B2 (fr) |
| CA (1) | CA2131185C (fr) |
| CZ (1) | CZ285589B6 (fr) |
| DE (1) | DE69300043T2 (fr) |
| DK (1) | DK0560268T3 (fr) |
| ES (1) | ES2066623T3 (fr) |
| FI (1) | FI944217A0 (fr) |
| GR (1) | GR3015622T3 (fr) |
| HU (2) | HUT70617A (fr) |
| IL (1) | IL105035A (fr) |
| NO (1) | NO302570B1 (fr) |
| NZ (1) | NZ251267A (fr) |
| OA (1) | OA10092A (fr) |
| PH (1) | PH30734A (fr) |
| PL (1) | PL176362B1 (fr) |
| RU (1) | RU2140911C1 (fr) |
| SK (1) | SK280161B6 (fr) |
| WO (1) | WO1993018003A1 (fr) |
| ZA (1) | ZA931776B (fr) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6071895A (en) | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
| ATE253050T1 (de) | 1992-03-11 | 2003-11-15 | Narhex Ltd | Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen |
| US5888992A (en) | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
| RU2126794C1 (ru) | 1992-03-11 | 1999-02-27 | Нархекс Лимитед | Аминопроизводные оксо- или гидроксизамещенных гидразинов, способ их получения и фармацевтические композиции для ингибирования ретровирусной протеазы |
| US5559256A (en) * | 1992-07-20 | 1996-09-24 | E. R. Squibb & Sons, Inc. | Aminediol protease inhibitors |
| JP3657002B2 (ja) | 1992-08-25 | 2005-06-08 | ジー．ディー．サール アンド カンパニー | レトロウイルスプロテアーゼ阻害剤として有用なα−およびβ−アミノ酸ヒドロキシエチルアミノスルホンアミド |
| US5846993A (en) * | 1992-12-22 | 1998-12-08 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| US5484926A (en) * | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| EP0610745A3 (en) * | 1993-02-09 | 1994-09-28 | Miles Inc | Novel aminomethylene derivatives as immunosuppressants. |
| IL110898A0 (en) * | 1993-09-10 | 1994-11-28 | Narhex Australia Pty Ltd | Polar-substituted hydrocarbons |
| US5527829A (en) * | 1994-05-23 | 1996-06-18 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| CA2137406C (fr) * | 1994-12-06 | 2005-09-13 | Pierre Louis Beaulieu | Procede de synthese d'intermediaires essentiels a la preparation d'inhibiteurs de la protease de vih |
| US6037157A (en) | 1995-06-29 | 2000-03-14 | Abbott Laboratories | Method for improving pharmacokinetics |
| US5914332A (en) | 1995-12-13 | 1999-06-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| US5883252A (en) * | 1996-01-26 | 1999-03-16 | Vertex Pharmaceuticals Incorporated | Aspartyl protease inhibitors |
| US5705647A (en) * | 1996-09-05 | 1998-01-06 | Agouron Pharmaceuticals, Inc. | Intermediates for making HIV-protease inhibitors |
| US5925759A (en) * | 1996-09-05 | 1999-07-20 | Agouron Pharmaceuticals, Inc. | Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors |
| US5962725A (en) | 1996-09-05 | 1999-10-05 | Agouron Pharmaceuticals, Inc. | Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir |
| US6232333B1 (en) | 1996-11-21 | 2001-05-15 | Abbott Laboratories | Pharmaceutical composition |
| US6001851A (en) * | 1997-03-13 | 1999-12-14 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| US6084107A (en) * | 1997-09-05 | 2000-07-04 | Agouron Pharmaceuticals, Inc. | Intermediates for making HIV-protease inhibitors |
| US6251906B1 (en) | 1998-05-15 | 2001-06-26 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| BR0011864A (pt) | 2000-01-19 | 2004-07-20 | Abbott Lab | Formulações farmacêuticas |
| US6992081B2 (en) | 2000-03-23 | 2006-01-31 | Elan Pharmaceuticals, Inc. | Compounds to treat Alzheimer's disease |
| ATE343562T1 (de) * | 2000-03-23 | 2006-11-15 | Elan Pharm Inc | Verbindungen und verfahren zur behandlung der alzheimerschen krankheit |
| EP1666452A2 (fr) | 2000-06-30 | 2006-06-07 | Elan Pharmaceuticals, Inc. | Composés pour le traitement de la maladie d'Alzheimer |
| PE20020276A1 (es) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
| US20030096864A1 (en) * | 2000-06-30 | 2003-05-22 | Fang Lawrence Y. | Compounds to treat alzheimer's disease |
| US6846813B2 (en) * | 2000-06-30 | 2005-01-25 | Pharmacia & Upjohn Company | Compounds to treat alzheimer's disease |
| DE60112942T2 (de) * | 2000-06-30 | 2006-06-22 | Elan Pharmaceuticals, Inc., South San Francisco | Verbindungen zur behandlung der alzheimerischen krankheit |
| MXPA04000140A (es) * | 2001-06-27 | 2004-06-03 | Elan Pharm Inc | Derivados de beta-hidroxiamina utiles en el tratamiento de enfermedad de alzheimer. |
| US20070213407A1 (en) * | 2001-06-29 | 2007-09-13 | Elan Pharmaceuticals And Pharmacia & Upjohn Company Llc | Compounds to treat Alzheimer's disease |
| JP4482883B2 (ja) | 2003-05-22 | 2010-06-16 | リードケミカル株式会社 | 抗ウイルス作用を有する化合物およびその配合剤 |
| EP2301919A1 (fr) * | 2004-06-10 | 2011-03-30 | Board of Trustees of Michigan State University | Synthèse du caprolactam à partir de la lysine |
| WO2007015805A1 (fr) * | 2005-07-20 | 2007-02-08 | Eli Lilly And Company | Composés joints en position 1-amino |
| EP2148856B8 (fr) * | 2007-02-20 | 2016-04-06 | Board of Trustees of Michigan State University | Déamination catalytique pour production de caprolactame |
| JP5448854B2 (ja) | 2007-03-12 | 2014-03-19 | ウェルズ ファーゴ バンク ナショナル アソシエイション | オリゴマー−プロテアーゼ阻害剤複合体 |
| US9095620B2 (en) | 2008-03-12 | 2015-08-04 | Nektar Therapeutics | Reagents |
| JP2011529087A (ja) * | 2008-07-24 | 2011-12-01 | ドラス コーポレイション | 環状アミドモノマーを作製する方法、ならびに関連する誘導体および方法 |
| US20120108501A1 (en) | 2009-06-12 | 2012-05-03 | Nektar Therapeutics | Protease Inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0264106B1 (fr) * | 1986-10-14 | 1994-03-16 | Banyu Pharmaceutical Co., Ltd. | Dérivés 5-substitués de l'acide amino-4-hydroxy-pentanoique et leur emploi |
| CA1340588C (fr) * | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Derive d'aminoacides |
| GB8927915D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Novel alcohols |
| GB8927913D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
| MY110227A (en) * | 1991-08-12 | 1998-03-31 | Ciba Geigy Ag | 1-acylpiperindine compounds. |
| ZA931777B (en) * | 1992-03-13 | 1993-09-23 | Bio Mega Boehringer Ingelheim | Substituted pyrrolidine derivatives as HIV protease inhibitors. |
| IL110255A (en) * | 1993-07-16 | 1998-12-06 | Merck & Co Inc | Creation and resolution of 2 tert-butylcarboxamidopiprazine |
| US5480887A (en) * | 1994-02-02 | 1996-01-02 | Eli Lilly And Company | Protease inhibitors |
| GB2292146A (en) * | 1994-08-11 | 1996-02-14 | Merck & Co Inc | HIV protease inhibitors useful for the treatment of AIDS |
-
1993
- 1993-03-09 DE DE69300043T patent/DE69300043T2/de not_active Expired - Lifetime
- 1993-03-09 ES ES93103712T patent/ES2066623T3/es not_active Expired - Lifetime
- 1993-03-09 AT AT93103712T patent/ATE116640T1/de active
- 1993-03-09 DK DK93103712.1T patent/DK0560268T3/da active
- 1993-03-09 EP EP93103712A patent/EP0560268B1/fr not_active Expired - Lifetime
- 1993-03-10 AP APAP/P/1993/000495A patent/AP393A/en active
- 1993-03-11 PH PH45862A patent/PH30734A/en unknown
- 1993-03-12 RU RU94040841A patent/RU2140911C1/ru active
- 1993-03-12 NZ NZ251267A patent/NZ251267A/en unknown
- 1993-03-12 CA CA002131185A patent/CA2131185C/fr not_active Expired - Lifetime
- 1993-03-12 WO PCT/CA1993/000096 patent/WO1993018003A1/fr active IP Right Grant
- 1993-03-12 AU AU38808/93A patent/AU670582B2/en not_active Ceased
- 1993-03-12 SK SK1090-94A patent/SK280161B6/sk unknown
- 1993-03-12 IL IL105035A patent/IL105035A/xx not_active IP Right Cessation
- 1993-03-12 PL PL93305166A patent/PL176362B1/pl unknown
- 1993-03-12 CZ CZ942232A patent/CZ285589B6/cs not_active IP Right Cessation
- 1993-03-12 HU HU9402613A patent/HUT70617A/hu unknown
- 1993-03-12 ZA ZA931776A patent/ZA931776B/xx unknown
- 1993-03-15 JP JP05414293A patent/JP3258422B2/ja not_active Expired - Fee Related
-
1994
- 1994-08-05 OA OA60550A patent/OA10092A/en unknown
- 1994-09-12 NO NO943383A patent/NO302570B1/no unknown
- 1994-09-13 KR KR1019940703190A patent/KR950700253A/ko active IP Right Grant
- 1994-09-13 FI FI944217A patent/FI944217A0/fi unknown
-
1995
- 1995-03-27 GR GR950400700T patent/GR3015622T3/el unknown
- 1995-06-23 HU HU95P/P00429P patent/HU211854A9/hu unknown
-
1996
- 1996-12-11 US US08/763,464 patent/US5807870A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK280161B6 (sk) | Substituované deriváty kyseliny pipekolínovej, spô | |
| CZ213594A3 (en) | Carboxamides, process of their preparation, their use and pharmaceutical preparations based thereon | |
| MX2008011667A (es) | Derivados de piperidinil, indolil, piridinil, morfolinil y bencimidazolil urea como inhibidores de epoxido hidrolasa soluble para el tratamiento de la hipertension, inflamaciones y otras enfermedades. | |
| SK11352001A3 (sk) | Metaloproteázový inhibítor kyselina sulfamátohydroxámová | |
| CZ296915B6 (cs) | Slouceniny inhibující proteázy retroviru | |
| CA2092653C (fr) | Utilisation de derives substitues de pyrrolidine comme inhibiteurs de la protease du vih | |
| DE69332770T2 (de) | Sulfonylalkanoylaminohydroxyethylaminosulfamidsäuren verwendbar als retrovirale Proteasehemmer | |
| SK282058B6 (sk) | Deriváty kyseliny octovej, spôsob ich výroby, farmaceutické prostriedky na ich báze a ich použitie na výrobu liečiv | |
| DE69116576T2 (de) | Aromatische sulfonamidderivate, ihre verwendung als enzyminhibitoren und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
| US5545640A (en) | Protease inhibiting succinic acid derivatives | |
| US5614533A (en) | Substituted pipecolinic acid derivatives as HIV protease inhibitors | |
| KR100469219B1 (ko) | 티아졸-유도체 | |
| EP0472077A2 (fr) | Pseudopeptides du type hydroxyéthylamine ou norstatine ayant un substituant de phosphonate | |
| SK7602003A3 (en) | Novel compounds for use as HIV protease inhibitors | |
| CN1096293A (zh) | 用作hiv蛋白酶抑制剂的取代2-哌啶酸衍生物 | |
| WO2004076429A1 (fr) | Derives ethynyl servant d'inhibiteurs du facteur xa | |
| CZ437098A3 (cs) | Deriváty thiazolu |